The product range includes research, development, and production of high-end medical devices such as fluorescence imaging series, fluorescence contrast agent drugs (ICG, targeted contrast agent series, etc.), and core components like fluorescence CMOS camera modules and endoscopes. These solutions have been implemented in over 500 large hospitals.
Founded in 2011, the focus remains on core technologies such as molecular fluorescence, Raman spectroscopy, AI, computer-aided drug molecular design (CADD), and AI-assisted drug design.
Recognized as a unicorn-incubating and specialized "little giant" enterprise, having undertaken numerous national, provincial, and municipal key research projects. Holds 131 core invention patents and 7 US invention patents.
Maintaining strategic partnerships with international leading companies in Germany and Japan, establishing cooperative business with more than 10 overseas countries.